← Leaderboards
Jonathan Patrick Schlebach
Purdue University
$5,247,034
Attributed
$6,273,253
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,273,253 · 6
By mechanism
R01$4,839,144 · 3
R35$911,492 · 1
R21$413,293 · 1
F32$109,324 · 1
Top collaborators
- Lars Plate3 shared
Most similar at Purdue University
Same institution · by research overlap
- Richard J. Kuhn$59,996,659
- Zhao-Qing Luo$7,419,104
- Timothy G Reese$71,168
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsLinkMutationCellsMembrane ProteinsSeriesInsightMembraneInvestigationProteostasisMutation ScreeningMolecular ChaperonesDefectMediatingTransmembrane DomainStructureMolecularBiochemicalPropertyVariantPolypeptideProtein DegradationEquilibriumIntegral Membrane Protein
Grant awards (18)
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants$686,508
R01 · FY2025 · HL · contact PI
Molecular Mechanisms of Membrane Protein Misfolding and Quality Control in Cellular Proteostasis$588,613
R35 · FY2025 · GM · contact PI
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants$678,226
R01 · FY2024 · HL · contact PI
Molecular Mechanisms of Membrane Protein Misfolding and Quality Control in Cellular Proteostasis$322,879
R35 · FY2024 · GM · contact PI
Stimulation of Ribosomal Frameshifting by Cotranslational Membrane Protein Folding and Misfolding$318,073
R01 · FY2024 · GM · contact PI
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants$687,705
R01 · FY2023 · HL · contact PI
Stimulation of Ribosomal Frameshifting by Cotranslational Membrane Protein Folding and Misfolding$304,820
R01 · FY2023 · GM · contact PI
Stimulation of Ribosomal Frameshifting by Cotranslational Membrane Protein Folding and Misfolding$305,061
R01 · FY2022 · GM · contact PI
Topological Energetics and the Cellular Quality Control of Integral Membrane Proteins$304,304
R01 · FY2022 · GM · contact PI
Stimulation of Ribosomal Frameshifting by Cotranslational Membrane Protein Folding and Misfolding$319,921
R01 · FY2021 · GM · contact PI
Topological Energetics and the Cellular Quality Control of Integral Membrane Proteins$304,612
R01 · FY2021 · GM · contact PI
Topological Energetics and the Cellular Quality Control of Integral Membrane Proteins$304,905
R01 · FY2020 · GM · contact PI
Topological Heterogeneity as an Evolved Source of Structural Diversity in Viral Polyproteins$186,959
R21 · FY2020 · AI · contact PI
Topological Energetics and the Cellular Quality Control of Integral Membrane Proteins$305,184
R01 · FY2019 · GM · contact PI
Topological Heterogeneity as an Evolved Source of Structural Diversity in Viral Polyproteins$226,334
R21 · FY2019 · AI · contact PI
Topological Energetics and the Cellular Quality Control of Integral Membrane Proteins$319,825
R01 · FY2018 · GM · contact PI
Structural Basis for the Partitioning of C99 into Liquid-Ordered Membrane Domains$56,042
F32 · FY2015 · GM · contact PI
Structural Basis for the Partitioning of C99 into Liquid-Ordered Membrane Domains$53,282
F32 · FY2014 · GM · contact PI